Publicaciones en colaboración con investigadores/as de Instituto de Investigación Sanitaria Gregorio Marañón (23)

2024

  1. ADAMTS13 recovery in acute thrombotic thrombocytopenic purpura after caplacizumab therapy

    Blood, Vol. 143, Núm. 18, pp. 1807-1815

  2. Avatrombopag in immune thrombocytopenia: A real-world study of the Spanish ITP Group (GEPTI)

    American Journal of Hematology

  3. Cardiac stasis imaging, stroke, and silent brain infarcts in patients with nonischemic dilated cardiomyopathy

    American Journal of Physiology - Heart and Circulatory Physiology, Vol. 327, Núm. 2, pp. H446-H453

2023

  1. An update on the pathogenesis and diagnosis of thrombotic thrombocytopenic purpura

    Expert Review of Hematology, Vol. 16, Núm. 1, pp. 17-32

  2. Immune thrombotic thrombocytopenic purpura: clinical suspicion and basic management in emergency departments — an expert review and consensus statement from the Spanish societies of hematology and hemotherapy (SEHH) and emergency medicine (SEMES)

    Emergencias, Vol. 35, Núm. 1, pp. 44-52

  3. Recommendations for the Clinical Approach to Immune Thrombocytopenia: Spanish ITP Working Group (GEPTI)

    Journal of Clinical Medicine, Vol. 12, Núm. 20

2022

  1. A Dalbavancin Lock Solution Can Reduce Enterococcal Biofilms After Freezing

    Infectious Diseases and Therapy, Vol. 11, Núm. 2, pp. 743-755

  2. Clinical grade production of IL-15 stimulated NK cells for early infusion in adult AML patients undergoing haploidentical stem cell transplantation with post-transplant cyclophosphamide

    Transfusion, Vol. 62, Núm. 2, pp. 374-385

  3. Novel Therapies to Address Unmet Needs in ITP

    Pharmaceuticals, Vol. 15, Núm. 7

2021

  1. A mild deficiency of ADAMTS13 is associated with severity in COVID-19: comparison of the coagulation profile in critically and noncritically ill patients

    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, Vol. 32, Núm. 7, pp. 458-467

  2. Acquired FXIII Deficiency is Associated with High Morbidity

    Thrombosis and Haemostasis, Vol. 122, Núm. 1, pp. 048-056

  3. Best practices and recommendations for drug regimens and plasma exchange for immune thrombotic thrombocytopenic purpura

    Expert Review of Hematology, Vol. 14, Núm. 8, pp. 707-719

  4. Incidence, diagnosis, and outcome of immune-mediated thrombotic thrombocytopenic purpura: A nationwide survey by the Spanish registry of thrombotic thrombocytopenic purpura

    Journal of Clinical Apheresis, Vol. 36, Núm. 4, pp. 563-573

  5. Multicentric evaluation of the new HemosIL Acustar® chemiluminescence ADAMTS13 activity assay

    International Journal of Laboratory Hematology, Vol. 43, Núm. 3, pp. 485-493

2020

  1. In Vitro Study to Evaluate the Bioactivity of Freezing a Heparin-Based Dalbavancin Lock Solution

    Antimicrobial Agents and Chemotherapy, Vol. 64, Núm. 12

  2. Retrospective Multicenter Study of Extracorporeal Photopheresis in Steroid-Refractory Acute and Chronic Graft-versus-Host Disease

    Biology of Blood and Marrow Transplantation, Vol. 26, Núm. 4, pp. 651-658

2019

  1. Mononuclear cell collection for extracorporeal photopheresis by using the “off-line” system: A comparative study between COBE Spectra and Spectra Optia devices

    Journal of Clinical Apheresis, Vol. 34, Núm. 4, pp. 359-366

2017

  1. Fatal anaphylaxis caused by gadolinium due to beta-tryptase–induced hemorragic diathesis

    Journal of Allergy and Clinical Immunology: In Practice, Vol. 5, Núm. 5, pp. 1433-1434

  2. Transient hemolysis due to anti-D and anti-A1 produced by engrafted donor's lymphocytes after allogeneic unmanipulated haploidentical hematopoietic stem cell transplantation

    Transfusion, Vol. 57, Núm. 10, pp. 2355-2358

2016

  1. Busulfan-based reduced intensity conditioning regimens for haploidentical transplantation in relapsed/refractory Hodgkin lymphoma: Spanish multicenter experience

    Bone Marrow Transplantation, Vol. 51, Núm. 10, pp. 1307-1312